Zevra Therapeutics Reports Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(c)(4)

E-Home (EJH) confronts Nasdaq delisting risk after $1 bid price failure

Merlin ends drought for Boston tech firms after listing this week on the Nasdaq exchange

Market risk a la 2022 (SP500:)

NASDAQ sinks 2% to a new 6-month trading low

Here's the Smartest Way to Invest in the S&P 500 in March